Patents by Inventor Fawzia Bardag-Gorce

Fawzia Bardag-Gorce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteasome modulation for treatment of corneal disorders
    Patent number: 10736934
    Abstract: Disclosed herein are methods and compositions useful for preventing or reducing corneal haze of opacification resulting from Limbal Stem Cell Deficiency (LSCD). The invention comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. The invention also comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. In addition, the invention comprises a method of administering to a subject suffering from corneal opacification with a sufficient amount of proteasome modulator, resulting in reduction of Keratin proteins in the cornea of the subject.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: August 11, 2020
    Assignee: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
    Inventor: Fawzia Bardag-Gorce
  • PROTEASOME MODULATION FOR TREATMENT OF CORNEAL DISORDERS
    Publication number: 20180369316
    Abstract: Disclosed herein are methods and compositions useful for preventing or reducing corneal haze of opacification resulting from Limbal Stem Cell Deficiency (LSCD). The invention comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. The invention also comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. In addition, the invention comprises a method of administering to a subject suffering from corneal opacification with a sufficient amount of proteasome modulator, resulting in reduction of Keratin proteins in the cornea of the subject.
    Type: Application
    Filed: November 11, 2016
    Publication date: December 27, 2018
    Inventor: Fawzia Bardag-Gorce